Cicletanine

西氯他宁

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCicletanine
Drug Alias Name沙克太宁cicletaninumJustar (HCl)TenstatenCycletanide +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha adrenergic receptor agonistsBeta adrenergic receptors agonists
TargetsAlpha adrenergic receptorBeta adrenergic receptors
Therapy Area/IndicationsHyponatremiaHypokalemiaDiabetes Mellitus +[5] 
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1988/01/01
Country/TerritoryBelgiumCanadaUnited States +[11] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesIpsen
China Registration ClassN/A

Develop Information

Active CompaniesNavitas PharmaIpsen Inc
Inactive CompaniesGilead Sciences Inc
Active IndicationsHyponatremiaHypokalemiaDiabetes Mellitus +[4] 
Inactive IndicationsPulmonary Arterial Hypertension

Other Information

ATC CodeC03BX03
Related LinksWikipediaKEGG